Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Articles by Brown JP, Prince RL, Deal C, et al. Comparison of the effect of denosumab, alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial. J Bone Miner Res. 2009, 24(1):153-161. doi: 10.1359/jbmr.080901.
Advertisement
Latest Updated Articles
- Study Summary: DECIDE
Published: June 29th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Expiring ACA Subsidies and CMS Payment Models Raise Costs for Consumers and Employers
2
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
3
FDA Approves Gene Therapy Onasemnogene Abeparvovec for Broader SMA Population
4
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
5
